Stocks Comparison
Natural Alternatives International vs Trulieve Cannabis: revenue, profit, margins and growth compared
Natural Alternatives International brought in $129.9M of revenue in fiscal 2025, Trulieve Cannabis $1.2B in fiscal 2025. Revenue changed by +14.1% at Natural Alternatives International and -0.4% at Trulieve Cannabis on the year before, so Natural Alternatives International grew faster. Natural Alternatives International kept -10.5% of its revenue as net profit, Trulieve Cannabis -9.9%. Free cash flow was $2.3M at Natural Alternatives International and $228.6M at Trulieve Cannabis.
Side by side, latest fiscal year
| NAII | TRLV | |
|---|---|---|
| Fiscal year ended | FY2025 (June 30, 2025) | FY2025 (December 31, 2025) |
| Revenue | $129.9M | $1.2B |
| Revenue growth | +14.1% | -0.4% |
| Net income | -$13.6M | -$116.4M |
| Net margin | -10.5% | -9.9% |
| Free cash flow | $2.3M | $228.6M |
| Free cash flow margin | 1.8% | 19.4% |
| Earnings per share (diluted) | -$2.28 | -$0.58 |
| Cash | $12.3M | $255.5M |
| Debt | n/a | $136.7M |
| Price to earnings | n/a | n/a |
| Market value | $11M | $2.4B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #286 of 646 · Health care | #138 of 646 · Health care |
Over the years
Questions about Natural Alternatives International and Trulieve Cannabis
Which is bigger by revenue, Natural Alternatives International or Trulieve Cannabis?
Trulieve Cannabis is bigger by revenue: $1.2B in fiscal 2025, against $129.9M for Natural Alternatives International in fiscal 2025.
Which keeps more of its revenue as profit, Natural Alternatives International or Trulieve Cannabis?
Natural Alternatives International had a net margin of -10.5% in fiscal 2025; Trulieve Cannabis had -9.9% in fiscal 2025.
Which grew revenue faster, Natural Alternatives International or Trulieve Cannabis?
In their latest fiscal years revenue changed by +14.1% at Natural Alternatives International and -0.4% at Trulieve Cannabis.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.